mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-13 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-10 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-09 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-09 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-09 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-09 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-07 |